CF
CNA Financial Portfolio holdings
AUM
$195M
This Quarter Return
-2.39%
1 Year Return
+20.43%
3 Year Return
+79.36%
5 Year Return
+144.91%
10 Year Return
+226.32%
AUM
$263M
AUM Growth
+$263M
(-8.1%)
Cap. Flow
-$2.71M
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
44.78%
Holding
186
New
13
Increased
27
Reduced
122
Closed
19
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$5.45M |
| 2 |
Devon Energy
DVN
|
$4.51M |
| 3 |
Cheniere Energy
LNG
|
$3.32M |
| 4 |
Enterprise Products Partners
EPD
|
$2.97M |
| 5 |
Meta Platforms (Facebook)
META
|
$2.71M |
Top Sells
| 1 |
Cigna
CI
|
$9.88M |
| 2 |
Ferguson
FERG
|
$3.6M |
| 3 |
AbbVie
ABBV
|
$1.34M |
| 4 |
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
$1.2M |
| 5 |
Rapid7
RPD
|
$842K |
Sector Composition
| 1 | Healthcare | 18.86% |
| 2 | Energy | 15.97% |
| 3 | Technology | 13.92% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Materials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
126
DELISTED
Blueprint Medicines
BPMC
| $441K | 0.17% |
6,699
-1,110
| -14% | -$73.1K |
|
127
DT Midstream
DTM
$10.5B
| $440K | 0.17% |
+8,470
| New | +$440K |
|
128
Americold
COLD
$4.01B
| $432K | 0.16% |
17,546
-1,007
| -5% | -$24.8K |
|
129
Varonis Systems
VRNS
$6.37B
| $429K | 0.16% |
16,166
-8,790
| -35% | -$233K |
|
130
Clarivate
CLVT
$2.82B
| $406K | 0.15% |
43,272
+9,701
| +29% | +$91K |
|
131
Kratos Defense & Security Solutions
KTOS
$11.2B
| $401K | 0.15% |
39,438
-2,262
| -5% | -$23K |
|
132
Five Below
FIVE
$8.26B
| $394K | 0.15% |
2,860
-1,700
| -37% | -$234K |
|
133
Life Time Group Holdings
LTH
$6.04B
| $391K | 0.15% |
40,152
-4,360
| -10% | -$42.5K |
|
134
Trex
TREX
$6.46B
| $390K | 0.15% |
8,865
-509
| -5% | -$22.4K |
|
135
PENN Entertainment
PENN
$2.92B
| $387K | 0.15% |
14,084
-808
| -5% | -$22.2K |
|
136
Insmed
INSM
$30.7B
| $380K | 0.14% |
17,644
-2,700
| -13% | -$58.2K |
|
137
Arrowhead Research
ARWR
$3.55B
| $367K | 0.14% |
11,100
-1,970
| -15% | -$65.1K |
|
138
Repay Holdings
RPAY
$488M
| $367K | 0.14% |
51,943
-2,980
| -5% | -$21.1K |
|
139
Intellia Therapeutics
NTLA
$1.22B
| $364K | 0.14% |
6,510
-2,090
| -24% | -$117K |
|
140
Madison Square Garden
MSGS
$4.7B
| $340K | 0.13% |
2,488
-143
| -5% | -$19.5K |
|
|
ISEE
141
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $325K | 0.12% |
+18,140
| New | +$325K |
|
142
Ascendis Pharma
ASND
$12.1B
| $308K | 0.12% |
2,985
-330
| -10% | -$34.1K |
|
143
PAR Technology
PAR
$2B
| $303K | 0.12% |
10,251
-589
| -5% | -$17.4K |
|
144
P10
PX
$1.35B
| $280K | 0.11% |
26,608
| – | – |
|
145
Legend Biotech
LEGN
$6.32B
| $274K | 0.1% |
6,715
+300
| +5% | +$12.2K |
|
146
Coherus Oncology, Inc. Common Stock
CHRS
$138M
| $273K | 0.1% |
28,451
-510
| -2% | -$4.89K |
|
|
ALTR
147
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $264K | 0.1% |
5,968
-343
| -5% | -$15.2K |
|
148
Jamf
JAMF
$1.21B
| $258K | 0.1% |
11,626
-667
| -5% | -$14.8K |
|
149
Holley
HLLY
$482M
| $257K | 0.1% |
63,411
-14,513
| -19% | -$58.8K |
|
150
Recursion Pharmaceuticals
RXRX
$2.02B
| $257K | 0.1% |
24,112
-5,360
| -18% | -$57.1K |
|